Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region

American Journal of Pathology

Volumn 153, Issue 1, 1998, Pages 287-294

  Wu, Tsung Teh ^a   Watanabe, Toshiaki ^a   Heitmiller, Richard ^a   Zahurak, Marianna ^a   Forastiere, Arlene A ^a   Hamilton, Stanley R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 5Q; CHROMOSOME LOSS; DNA REPLICATION; DYSPLASIA; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031819882     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65570-8     Document Type: Article

References (54)

1. Blot WJ: Esophageal cancer trends and risk factors. Semin Oncol 1994, 2:403-410
2. Heitmiller RF, Sharma RR: Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma. J Thorac Cardiovasc Surg 1996, 112:130-136
3. Haggitt RC: Barrett's esophagus, dysplasia and adenocarcinoma. Hum Pathol 1994, 25:982-993
4. Spechler SJ: Barrett's esophagus. Gastroenterologist 1994, 2;273-284
5. Hamilton SR, Smith RRL: The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987, 87:301-312
6. Hameeteman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG: Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989, 96:1249-1256
7. Blount PL, Ramel S, Raskind WH, Haggitt RC, Sanchez CA, Dean PJ, Rabinovitch PS, Reid BJ: 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res 1991, 51:5482-5486
8. Younes M, Lebovitz RM, Lechago LV, Lechago J: p53 protein accumulation in Barrett's metaplasia, dysplasia and carcinoma: a follow-up study. Gastroenterology 1993, 105:1637-1642
9. Hamelin R, Flejou JF, Muzeau F, Potet F, Laurent-Puig P, Fekete F, Thomas G: TP53 gene mutations and p53 protein immunoreactivity in malignant, and premalignant Barrett's epithelium. Gastroenterology 1994, 107:1012-1018
10. WAF1/CIP1/SDI1 gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction. Hum Pathol 1996, 27:1211-1220
11. Neshat K, Sanchez CA, Galipeau PC, Blount PL, Levine DS, Joslyn G, Reid BJ: P53 mutations m Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 1994, 106:1589-1595
12. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, Rabinovitch PS, Reid BJ: 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci 1996, 93:7081-7084
13. Schneider PM, Casson AG, Levine B, Garewal HS, Hoelscher AH, Becker K, Dittler HJ, Cleary KR, Troster M, Seiwert JR, Roth JA: Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. J Thorac Cardiovasc Surg 1996, 111:323-331
14. Ireland AP, Clark GW, DeMeester TR: Barrett's esophagus: the significance of p53 in clinical practice. Ann Surg 1997, 225:17-30
15. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ: Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genomic amplification and microsatellite polymorphisms. Oncogene 1996, 12:1873-1878
16. Hammound ZT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA, Goodfellow PJ: Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequence on the long arm of chromosome 4. Cancer Res 1996, 56:4499-4502
17. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ, Meltzer SJ: Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 1992, 52:6525-6530
18. Meltzer SJ: The molecular biology of esophageal carcinoma. Recent Results Cancer Res 1996, 142:1-8
19. Montesano R, Hollsein M, Hainaul P: Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996, 69:225-235
20. Barrett MT, Sanchez CA, Galipeau PC, Neshat K, Emond M, Reid BJ: Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 1996, 13:1867-1873
21. Powell SM, Papadopoulos N, Kinzler KW, Smolinski KN, Meltzer SJ: APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology 1994, 107:1759-1763
22. Barrett MT, Schutte M, Kern SE, Reid BJ: Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res 1996, 56:4351-4353
23. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SHE: Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated esophageal adenocarcinoma. Cancer Res 1996, 56:259-263
24. Meltzer SJ, Yin J, Manin B, Rhyu MG, Cottrell J, Hudson E, Redd JL, Krasna MJ, Abraham JM, Reid BJ: Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinoma. Cancer Res 1994, 54:3379-3382
25. Keller G, Rotter M, Vogelsang H, Bischoff P, Becker KF, Mueller J, Brauch H, Siewert JR, Hofler H: Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract: relation to clinicopathological data and family history. Am J Pathol 1995, 147:593-600
26. Hamilton SR, Smith RRL, Cameron JL: Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988, 19:942-948
27. Hermanek P, Sobin LH: TNM Classification of Malignant Tumors, International Union Against Cancer (UICC), ed 4. New York, Springer-Verlag, 1992
28. Hermanek P, Henson DE, Hutter RVP, Sobin LH: TNM Supplement. New York, Springer-Verlag, 1993
29. Moskaluk CA, Kern SE: Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 1997, 150:1547-1552
30. Bankfalvi A, Navabi H, Bier B, Bocker W, Jasani B, Schmid KW: Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol 1994, 174:223-228
31. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR: An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994, 172: 5-12
32. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481
33. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748
34. Cox DR: Regression models and life tables (with discussion). J R Stat Soc 1972, 34:187-220
35. Jessurun J, Romero-Guadarrama M, Manievel JC: Cecal poorly differentiated adenocarcinoma, medullary type. Mod Pathol 1992, 5:43A
36. Cameron AJ, Ott BJ, Payne WS: The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985, 313:857-859
37. Cameron Aj, Lomboy CT, Pera M, Carpenter HA: Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995, 109:1541-1546
38. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS: Flow-cytometric and histological progression to malignancy in Barrett's esophagus, prospective endoscopic surveillance of a cohort. Gastroenterology 1992, 102:1212-1219
39. Blount PL, Meltzer SJ, Yin J, Huang Y, Krasna MJ, Reid BJ: Clonal ordering of 17p and 5q allelic loses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci 1993, 90:3221-3225
40. Blount PL, Galipeau PC, Sanchez CA, Neshat K, Levine DS, Yin J, Suzuki H, Abraham JM, Meltzer SJ, Reid BJ: 17p allelic losses in dipoid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res 1994, 54:2292-2295
41. Zhuang Z, Vortmeyer AO, Mark EJ, Odez R, Emmert-Burk MR, Merino MJ, Moon H, Liotta LA, Duray PH: Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res 1996, 56:1961-1964
42. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SEH: Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence. Genes Chromosomes Cancer 1998, 21:49-60
43. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
44. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Russell SHE: Base transitional at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res 1995, 55:3406-3411
45. Kim H, Jen J, Vogelstein B, Hamilton SR: Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994, 145:148-156
46. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 1993, 260:816-819
47. Dos Santos NR, Seruca R, Constancia M, Seixas M, Sobrinho-Simoes: Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology 1996, 110:38-44
48. Heitmiller RF, Redmond M, Hamilton SR: Barrett's esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy. Ann Surg 1996, 224:66-71
49. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC: Barrett's esophagus with high-grade dysplasia: an indication for esphagectomy? Ann Thorac Surg 1992, 54:199-204
50. Altorki NK, Sunagawa M, Little AG, Skinner DB: High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991, 161:97-100
51. Overholt Bf, Panjehpour M: Photodynamic therapy for Barrett's esophagus: clinical update. Am J Gastroenterol 1996, 91:1719-1723
52. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rush VW, Reid BJ: An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993, 105:40-50
53. Paraf F, Flejou JF, Pignon JP, Fekete F, Potet F: Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol 1995, 19:183-191
54. Coggi G, Bosari S, Roncalli M, Graziani D, Bossi P, Viale G, Buffa R, Ferrero S, Piassa M, Blandamura S, Segalin A, Bonavina L, Peracchia A: p53 protein accumulation and p53 gene mutation in esophageal carcinoma. Cancer 1997, 79:425-431